Evidence map›Paper›PMID 35847738›Full record

ArticleEJHaem2020

Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect

Jeff P Sharman, Kim Cocks, Chadi Nabhan, Nicole Lamanna, Neil E Kay, David L Grinblatt, Christopher R Flowers, Matthew S Davids, Pavel Kiselev, Arlene S Swern and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jeff P SharmanWillamette Valley Cancer Institute US Oncology Eugene Oregon USA.ORCID https://orcid.org/0000-0001-5611-6115
Kim CocksAdelphi Values Bollington Cheshire UK.
Chadi NabhanCaris Life Sciences Dallas Texas USA.
Nicole LamannaDivision of Hematology and Oncology Department of Medicine New York-Presbyterian/Columbia University Medical Center New York New York USA.
Neil E KayDivision of Hematology Mayo Clinic Rochester Minnesota USA.
David L GrinblattNorthShore University HealthSystem Evanston Illinois USA.
Christopher R FlowersMD Anderson Cancer Center University of Texas Houston Texas USA.
Matthew S DavidsDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Pavel KiselevBristol Myers Squibb Princeton New Jersey USA.
Arlene S SwernBristol Myers Squibb Princeton New Jersey USA.
Kristen SullivanBristol Myers Squibb Princeton New Jersey USA.
Mecide M GhariboBristol Myers Squibb Princeton New Jersey USA.
E Dawn FlickBristol Myers Squibb Princeton New Jersey USA.
Andrew TriggAdelphi Values Bollington Cheshire UK.
Anthony MatoMemorial Sloan Kettering Cancer Center New York New York USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health-related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) is important in guiding treatment decisions. However, the impact of CLL treatment initiation on HRQoL is unclear. We assessed HRQoL using the FACT-Leu and EQ-5D-3L questionnaires in the Connect

Indexed as

chronic lymphocytic leukemiafirst‐line therapylymphocytesquality of liferegistry

Identifiers

PMID35847738
PMCPMC9176138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.